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Enhanced expression of vsmNOS mRNA in glomeruli from
rats with unilateral ureteral obstruction
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Department of Hygiene and Preventive Medicine, Faculty of Medicine, Saitama Medical School, Saitama, and
Third Department of Internal Medicine, Gunma University School of Medicine, Gunma, Japan
expression of vsmNOS mRNA in glomeruli originates in mes-Enhanced expression of vsmNOS mRNA in glomeruli from
angial and epithelial cells in SOC rats and rats with UUO.rats with unilateral ureteral obstruction.
Background. The vasodilatory/cytotoxic gas, nitric oxide
(NO), is associated with an alteration in glomerular hemody-
namics seen after the induction of ureteral ligation. As yet the It is known that nitric oxide synthase (NOS) proteinstype of nitric oxide synthase (NOS) protein involved in the
biosynthesize the vasodilatory/cytotoxic gas, nitric oxidemechanism has not been clearly established in the unilateral
(NO) from the terminal guanidino nitrogen of l-arginineureteral obstruction (UUO) model.
Methods. Using reverse transcription (RT)-polymerase chain through its oxidative effect [1]. A family of NOS proteins
reaction (PCR), the expression and localization of vascular smooth are classified into the constitutive types, brain NOS
muscle-derived nitric oxide synthase (vsmNOS) mRNA were (bNOS) and endothelial NOS (eNOS) and the inducibleexamined in glomeruli from sham-operated control (SOC) rats
(i) types, macrophage-derived NOS (macNOS), hepato-and rats with UUO of three hours duration. Moreover, the
cyte-derived NOS and vascular smooth muscle-derivedeffect of endogenous angiotensin II on the expression of
vsmNOS mRNA in glomeruli was explored using SOC rats NOS (vsmNOS) [2]. Ordinarily, iNOS protein is ex-
and rats with UUO that were pretreated or not with enalapril, pressed in response to lipopolysaccharide and certain
an angiotensin-converting enzyme inhibitor. cytokines [3]. It was recently documented that vsmNOS
Results. The expression of vsmNOS mRNA was significantly
mRNA or protein was constitutively expressed in glo-greater in glomeruli of rats with UUO than in those of SOC
meruli [2, 4] or in the terminal afferent arteriole and thickrats. In rats with UUO, the expression of vsmNOS mRNA was
substantially increased in glomeruli of the obstructed kidney ascending limb of Henle [5] of the normal rat kidney.
(OK) compared to the contralateral, nonobstructed kidney However, the localization of vsmNOS mRNA and pro-
(CLK). Suppression of angiotensin II production in vivo with tein is not yet evident in glomeruli.
enalapril restored the expression of vsmNOS mRNA in glomer- Following unilateral ureteral obstruction (UUO),uli of the CLK and OK from rats with UUO to levels compara-
there is a deterioration of glomerular hemodynamics inble to that seen in glomeruli from SOC rats. In addition, the
the obstructed kidney (OK) [6]. This alteration may bein situ RT-PCR analysis, a novel method for mRNA identifica-
tion in cells and tissue, revealed that vsmNOS mRNA was the result of increased action of vasoconstrictors such as
expressed in the cytoplasm of glomerular mesangial and epithe- angiotensin II, thromboxane A2 and endothelin-1 versus
lial cells in SOC rats and rats with UUO. vasodilators such as prostaglandin E2, prostacyclin andConclusions. An increase in vsmNOS mRNA expression in
NO that occurs after the induction of ureteral obstructionglomeruli of the CLK and OK from rats with UUO may be
[6–9]. In particular, angiotensin II plays a central role inmediated by increased action of endogenous angiotensin II
that occurs after the onset of ureteral obstruction. Enhanced the aggravation of glomerular hemodynamics by enhanc-
expression of vsmNOS mRNA in glomeruli of the OK com- ing the production of the vasoconstrictors thromboxane
pared to the CLK may be due to differences in levels of angio- A2 [7] and most likely endothelin-1 [10], in addition totensin II acting on the two kidneys in vivo. Additionally, the
its vasoconstrictive action. Thus far, it is not evident
which of the NOS proteins is involved in the alteration in
glomerular hemodynamics observed in the UUO model.Key words: inducible nitric oxide synthase, ureteral obstruction, angio-
tensin II, glomerulus, enalapril. In a preliminary experiment, we also found constitu-
tively existing vsmNOS mRNA in glomeruli from sham-
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the effect of ureteral ligation on the expression of through the bifurcation of the aorta [7]. The kidneys
were immediately harvested, decapsulated and dissectedvsmNOS mRNA in glomeruli using the kidneys from
SOC rats and the contralateral nonobstructed kidney on ice into cortices and medullas. Glomeruli were then
obtained from cortices by sieving techniques (mesh sizes:(CLK), and OK from rats with UUO. Moreover, we
investigated the potential role of endogenous angioten- 250, 150 and 75 mm) [7, 11]. The glomeruli isolated were
washed twice and resuspended in ice-cold PBS. Thesin II in the expression of vsmNOS mRNA in glomeruli
using SOC rats and rats with UUO that were pretreated preparations were confirmed to consist of .90% isolated
glomeruli by light microscopy.or not with the angiotensin-converting enzyme (ACE)
inhibitor, enalapril. Additionally, we explored the local-
Preparation of RNAization of vsmNOS mRNA and protein in glomeruli from
SOC rats and rats with UUO with in situ RT-PCR analy- Total RNA was extracted from glomeruli using the
method of guanidinium thiocyanate [12, 13]. In brief, glo-sis, a new technique for mRNA identification in cells
and tissue and immunohistochemical staining. meruli were homogenized in 1 mL of ice-cold ISOGEN
[13]. Total RNA was precipitated with 500 mL of isopro-
panol. The RNA pellets were then washed with 1 mL of
METHODS
75% ethanol, dried and dissolved in RNase-free distilled
Animals, chemicals and reagents water. The quantitative analysis of total RNA was car-
ried out at 260 nm and 280 nm using a Beckman UV 640Female Sprague-Dawley rats weighing approximately
200 g were purchased from Clea Japan Inc. (Tokyo, spectrophotometer. The OD260/OD280 ratio of all RNA
samples used was over 1.8.Japan). Enalapril, an ACE inhibitor, was kindly provided
by Merk, Sharp & Dohme (Rahway, NJ, USA). ISOGEN,
cDNA synthesis and amplificationa reagent for RNA isolation, was supplied by Nippon
Gene (Toyama, Japan). Proteinase K, DNAse and RNA To examine the expression of vsmNOS and macNOS
mRNA, RT-PCR was performed as described previouslyPCR kits were obtained from Takara Biochemicals (Shiga,
Japan) AmpliTaq DNA polymerase was purchased from [13]. Total RNA from glomeruli was reverse transcribed
to first-strand cDNA in a reaction mixture consistingPerkin Elmer (Norwalk, CT, USA). In Situ Hybridiza-
tion kits were obtained from Dako Corp. (Carpenteria, of RT buffer (10 mmol/L Tris-HCl, 50 mmol/L KCl, 5
mmol/L MgCl2, 1 mmol/L deoxynucleotide triphosphateCA, USA). Rabbit antiserum against iNOS protein de-
rived from mouse macrophages was supplied by Affinity (dNTP) mixture and 1 U/mL RNase inhibitor), 0.25 U/mL
avian myeloblastosis virus (AMV) reverse transcriptaseBioreagents, Inc. (Rahway, NJ, USA).
and 2.5 mmol/L random primers under the particular
Experimental design incubation conditions (308C for 10 min and 428C for
30 min) controlled by a Programmed Thermal CyclerProtocol 1. To examine the effect of ureteral ligation
on the expression of vsmNOS mRNA in glomeruli, rats System (Astec, Tokyo, Japan). Following the incubation
period, the reaction mixture was heated at 998C for fivewere subjected to UUO or sham operation as reported
previously [7]. Both ureters were exposed through a mid- minutes and immediately chilled to 48C.
Polymerase chain reaction amplification was performedline abdominal incision under light ether anesthesia and
the left ureter was ligated near the bladder with 4-0 silk. for vsmNOS, macNOS and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) cDNA from glomeruli. Briefly,In SOC rats, the ureters were similarly visualized but
not ligated. Kidneys were harvested under light ether vsmNOS (600 bp) and macNOS (577 bp) cDNA were
amplified in a reaction mixture consisting of PCR ampli-anesthesia immediately after sham operation or ligation,
and 3, 6, 12 and 18 hours following sham operation or fication buffer (10 mmol/L Tris-HCl, 50 mmol/L KCl, 2.5
mmol/L MgCl2, 200 mmol/L dNTP mixture), 0.025 U/mLobstruction.
Protocol 2. To examine a role of endogenous angio- Takara Taq DNA polymerase, 1 mmol/L primers for each
cDNA amplification (vsmNOS sense: 59-TTGTGTCAtensin II in the expression of vsmNOS mRNA in glomer-
uli from rats with UUO, rats were intraperitoneally given GCCCTCAGAGTAC-39 and antisense: 59-CTGCAG
GATGTCTTGAACGTA-39 [14] and macNOS, sense:either saline alone or 10 mg/kg of enalapril dissolved in
saline at 24 hours, 12 hours and 1 hour prior to sham 59-GATCAGGAACCTGAAGCCCC-39 and antisense:
59-GCCCTTTTTTGCCCCATAGG-39 [15]) and re-operation or obstruction [7]. Kidneys were taken out
under light either anesthesia three hours following sham verse-transcribed cDNA from 1 mg of total RNA under
the following conditions: denaturation at 948C for oneoperation or obstruction.
minute, annealing at 658C for one minute and extension
Preparation of glomeruli at 728C for two minutes. The housekeeping gene,
GAPDH cDNA (515 bp) was coamplified under thePrior to isolating glomeruli, both kidneys were thor-
oughly perfused with phosphate buffered saline (PBS) same amplification protocol using a reaction mixture
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Fig. 1. PCR amplification of vsmNOS (600
bp) and GAPDH (515 bp) cDNA obtained
by reverse transcription of 1 mg RNA iso-
lated from glomeruli of the obstructed kid-
ney from rats with unilateral ureteral ob-
struction of three hours durations. Each
cDNA was amplified with 25 to 50 cycles
using specific primers. Abbreviations are:
PCR, polymerase chain reaction; vsmNOS,
vascular smooth muscle-derived inducible
nitric oxide synthase; GAPDH, glyceralde-
hyde-3-phosphate dehydrogenase.
composed of PCR amplification buffer, 0.025 U/mL Ta- In situ RT-PCR
kara Taq DNA polymerase, 1 mmol/L GAPDH cDNA Longitudinally sliced preparations (2 to 3 mm) of per-
amplification primers (sense: 59-AATGCATCCTG- fused kidneys were fixed at 48C overnight with 4% para-
CACCACCAA-39 and antisense: 59-GTAGCCATATT- formaldehyde dissolved in PBS and mounted in paraffin
CATTGTCATA-39) [4, 13, 16] and reverse-transcribed blocks. The preparations were cut at a thickness of 8 mm
cDNA from 1 mg of total RNA. and placed on microscopic slides. To remove paraffin, the
In a preliminary experiment, the maximal expression tissue sections were incubated serially in xylene (10 min,
of glomerular vsmNOS mRNA was observed in the OK 33), 99.5% ethanol (5 min, 32), 95% ethanol (3 min, 32),
90% ethanol (3 min, 31) and 70% ethanol (3 min, 31).from rats at three hours following UUO. Accordingly,
After washing for five minutes with distilled water, theglomerular cDNA from the OK of rats with UUO of
tissue preparations were permeabilized by 0.001% pro-three hours duration was utilized for the determination
teinase K digestion and immersed twice for five minutesof PCR cycles. As shown in Figure 1, vsmNOS or
each in TBS consisting of 50 mmol/L Tris-HCl, pH 7.8,GAPDH cDNA obtained from glomeruli of the OK
0.05% Tween 20, 0.3 mol/L NaCl and 0.02% NaN3. Sub-from rats with UUO of three hours duration was ampli-
sequently, genomic DNA of the preparations was de-fied with 25, 30, 35, 40, 45 and 50 cycles. There was a
composed by 5 U/mL DNase treatment. The DNase usedlinear increase in vsmNOS cDNA for 35 to 45 cycles
was then inactivated by heat treatment (958C for 5 min).and a linear rise in GAPDH cDNA for 30 to 40 cycles.
The sections were washed twice for five minutes eachSimilarly, macNOS cDNA amplification primers pro-
with TBS, dehydrated through graded ethanol and driedduced a linear increase in the cDNA for 35 to 45 cycles
at room temperature.(not shown) [15]. Thus, in the present study 40 cycles
To examine the localization of vsmNOS mRNA inwere used for the vsmNOS, macNOS and GAPDH
glomeruli, in situ RT-PCR was carried out according tocDNA amplifications. In addition, a pair of primers for
essentially the same protocol as described above usingvsmNOS, macNOS or GAPDH cDNA amplification has
a Gene Amp In Situ PCR System 1000 (Perkin Elmer).
been confirmed to specifically amplify the objective
In brief, kidney sections were incubated in RT buffer
cDNA by sequencing [14–16]. added to 0.5 U/mL AMV reverse transcriptase and 10
mmol/L random primers under the following thermal
Semiquantitative analysis of PCR products
cycle conditions: 308C for 10 minutes, 428C for 30 min-
Polymerase chain reaction amplification products were utes, 998C for 5 minutes, and 48C for 5 minutes. After
separated by means of a 2.0% agarose gel with ethidium RT of total RNA to first-strand cDNA, the sections were
bromide (0.5 mg/mL). The gel visualized with UV light washed three times for 5 minutes each with 23 saline
was photographed with Polaroid Type 667 positive film. sodium citrate, dehydrated by graded ethanol washes
The intensity of bands was measured by densitometry and dried at room temperature. Successively, vsmNOS
for semiquantitation. The relative levels of vsmNOS or cDNA was amplified in PCR amplification buffer con-
macNOS mRNA were determined by normalizing the taining 0.2 U/mL AmpliTaq DNA polymerase and 1
quantity of vsmNOS or macNOS cDNA to the amount mmol/L vsmNOS amplification primers under the follow-
ing conditions: denaturation at 948C for one minute, an-of GAPDH cDNA.
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nealing at 658C for one minute, and extension at 728C for for five minutes each, the sections were further incubated
for 20 minutes with biotin-conjugated second antibodytwo minutes. The sections were then dehydrated through
graded ethanol and dried at room temperature. In a pre- (Ab) (LSAB 2 kit; Dako Corp.) in TBS containing 0.1%
BSA. The sections were thoroughly washed with TBS,liminary experiment, vsmNOS cDNA in glomeruli of the
OK was amplified with 20, 25, 30, 35 and 40 cycles to reacted with horseradish peroxidase-labeled streptavidin
and stained with 0.3% diaminobenzidine. Following nu-determine the appropriate number of PCR cycles. The
optimal vsmNOS cDNA amplification was obtained with cleus stain with hematoxylin the sections were mounted
with 2 mg/mL p-phenylenediamine in 50% glycerol.30 cycles when examined by light microscopy after in
situ hybridization for vsmNOS cDNA (see later in the Antiserum against iNOS protein was obtained by im-
munizing rabbits with the peptide CKKGSALEEPKAtext). Therefore, in this study 30 cycles were utilized for
the vsmNOS cDNA amplification. TRL representing amino acids 1131–1144 of the 130 kD
form of mouse macrophage NOS protein. This peptide
In situ hybridization and color development possessed an additional N-terminal cysteine residue for
the conjunction to keyhole limpet hemocyanine. TheKidney sections amplified by PCR were prehybridized,
hybridized and washed using protocols developed by antiserum obtained had no cross-reactivities with bNOS
and eNOS proteins when examined by Western blotDako Corp. for the In Situ Hybridization kits. In a pre-
liminary experiment, the sense or antisense vsmNOS analysis [13].
cDNA amplification primer, which was end-labeled with
Statistical analysisbiotin, was hybridized with vsmNOS cDNA amplified.
The sense primer was hybridized with the vsmNOS All data reported represent means 6 SE. Intragroup
comparisons were performed by Duncan’s multiple rangecDNA much more intensely than the antisense primer.
Thus, the sense primer was used as a hybridization probe comparison test. Intergroup comparisons were based on
analysis of variance (ANOVA) with Student’s t-test.in this study. After hybridization, the biotin-labeled hy-
bridization probe was reacted with alkaline phosphatase-
conjugated streptoavidine. Staining was then performed
RESULTS
in a solution consisting of 100 mmol/L Tris-HCl, pH 9.5,
Table 1 shows the time course data of vsmNOS mRNA5 mmol/L MgCl2, 100 mmol/L NaCl, 0.0075% 5-bromo-
expression in glomeruli from SOC rats (N 5 5) and rats4-chloro-3-indolyl phosphate and 0.015% nitroblue tet-
with UUO (N 5 5). Detectable amounts of vsmNOSrazolium. The sections were dehydrated through graded
mRNA were observed in glomeruli from SOC rats,ethanol and mounted with 2 mg/mL p-phenylenediamine
where vsmNOS protein is known to be an induciblein 50% glycerol. Kidney sections that were not treated
enzyme. The expression of vsmNOS mRNA in glomeruliwith DNase were used as a positive control. Again, kid-
of the CLK and OK from rats with UUO peaked atney sections that were amplified without the addition of
three hours following ureteral obstruction and was sig-AmpliTaq DNA polymerase were utilized as a negative
nificantly increased by 5.4 and 8.8 times, respectively,control.
above the sham-operated control value. Subsequently,
Immunohistochemical study the significant increase in vsmNOS mRNA was observed
up to 12 hours in glomeruli of the CLK and at least upThe immunohistochemical analysis was carried out as re-
to 18 hours in glomeruli of the OK. Again, the expressionported previously [13]. The kidney preparations mounted
of vsmNOS mRNA maximized at three hours followingin paraffin blocks were cut at a thickness of 5 mm and
ureteral obstruction was significantly greater by 1.6 timesplaced on microscopic slides. To remove paraffin the
in glomeruli of the OK than in those of the CLK.tissue sections were incubated for three minutes each
Table 2 shows data on the relative levels of macNOSserially in xylene (33), 99.5% ethanol (32) and 70%
mRNA in glomeruli from SOC rats (N 5 5) and ratsethanol (31). The sections were washed in a gently run-
with UUO (N 5 5) at 0, 3, 6 and 12 hours followingning stream of tap water for three minutes (31) and
surgery. As shown in Figure 2, the expression of macNOSimmersed in distilled water for one minute (32). Endog-
mRNA was slightly, but clearly detected in glomeruli ofenous peroxidase activity of the kidney preparations was
the normal kidney from SOC rats. This observation wasinactivated by 0.3% hydrogen peroxide treatment. The
consistent with that reported previously [13, 17]. As well,kidney sections were then blocked for 10 minutes in a
the expression of macNOS mRNA was identified in glo-blocking solution (20% Block Ace), washed twice for
meruli of the CLK and OK from rats with UUO (Fig.five minutes each in TBS and incubated for two hours
2). No substantial changes in macNOS mRNA expres-with antiserum against iNOS protein (1:1000 dilution)
sion were observed at least up to 12 hours followingin TBS containing 0.1% bovine serum albumin (BSA).
surgery in glomeruli from SOC rats and rats with UUO.The same dilution of preimmune serum was used as a
negative control. After washing with TBS three times In addition, there were no significant differences in the
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Table 1. Time course of vsmNOS mRNA expression in glomeruli from rats subjected to sham operation or unilateral ureteral obstruction
Time after surgery hours
0 3 6 12 18
Sham 0.9160.08 0.8560.06 0.9560.04 0.8760.03 0.8060.04
CLK 1.0660.19 0.5860.49ad 3.4060.60cf 1.7160.16ce 0.6760.04
OK 0.9660.13 7.5260.49adg 4.1160.65be 2.0360.40f 1.5560.23fh
The time course for vsmNOS mRNA expression in glomeruli of the kidneys from sham-operated control rats (Sham) and in glomeruli of the contralateral,
nonobstructed kidney (CLK), and the obstructed kidney (OK) from rats with unilateral ureteral obstruction is shown. Kidneys were harvested immediately after
sham operation or ureteral ligation, and 3, 6, 12 and 18 hours following sham operation or ureteral obstruction. Data reported represent means (arbitrary units) 6
SE of values obtained from five separate glomerular preparations. Intragroup comparisons were done using Duncan’s multiple range comparison test. Intergroup
comparisons were performed by one-way ANOVA with Student’s t-test.
a P , 0.005, b P , 0.01 and c P , 0.05 compared to each basal (Time 0) value
d P , 0.005, e P , 0.01 and f P , 0.05 compared to each sham-operated control value
g P , 0.005 and h P , 0.05 comparing each OK value with the CLK value. Abbreviation is: vsmNOS, vascular smooth muscle-derived inducible nitric oxide
synthase.
Table 2. Relative levels of macNOS mRNA in glomeruli from rats
subjected to sham operation or unilateral ureteral obstruction
Time after surgery hours
0 3 6 12
Sham 0.4160.07 0.3460.02 0.3460.01 0.3560.03
CLK 0.3660.08 0.3160.05 0.3560.03 0.4560.06
OK 0.3960.05 0.3260.03 0.3860.04 0.4260.08
Relative levels of macNOS mRNA were examined in glomeruli of the kidneys
from sham-operated control rats (Sham) and in glomeruli of the contralateral,
nonobstructed kidney (CLK) and the obstructed kidney (OK) from rats with
unilateral ureteral obstruction. Kidneys were harvested immediately after sham
operation or ureteral ligation, and 3, 6 and 12 hours following sham operation
or ureteral obstruction. Data reported represent means (arbitrary units) 6 SE
of values obtained from five separate glomerular preparations. Intragroup com-
parisons were done using Duncan’s multiple range comparison test. Intergroup
comparisons were performed by one-way ANOVA. Abbreviation is: macNOS,
macrophage-derived inducible nitric oxide synthase.
Fig. 3. Relative levels of vsmNOS mRNA in glomeruli from sham-
operated control rats and rats with unilateral ureteral obstruction that
were pretreated with saline or the angiotensin-converting enzyme inhib-
itor, enalapril. Comparisons were performed by two-way ANOVA with
Student’s t-test. Abbreviations are: vsmNOS, vascular smooth muscle-
derived inducible nitric oxide synthase; CLK, contralateral, nonob-
structed kidney; OK, obstructed kidney.
expression of macNOS mRNA among glomeruli of the
three kidney groups from SOC rats and rats with UUO,
indicating that the expression of macNOS mRNA is not
essentially potentiated at least up to 12 hours followingFig. 2. PCR amplification of macNOS (515 bp) and GAPDH (515 bp)
cDNA obtained by reverse transcription of 1 mg RNA isolated from glo- the induction of ureteral ligation in glomeruli of the CLK
meruli of rats at three hours following sham operation or unilateral ure- and OK from rats with UUO.teral obstruction. Each cDNA was amplified with 40 cycles using specific
Figure 3 shows data on the relative levels of vsmNOSprimers. (A) presents cDNA from glomeruli of the sham-operated control
kidney. (B) presents cDNA from glomeruli of the contralateral, nonob- mRNA in glomeruli from SOC rats (N 5 5) and rats
structed kidney. (C) presents cDNA from glomeruli of the obstructed
with UUO (N 5 5) that were pretreated or not withkidney. Abbreviations are: PCR, polymerase chain reaction; macNOS,
macrophage-derived inducible nitric oxide synthase; GAPDH, glyceral- the ACE inhibitor, enalapril. As shown in Table 1, the
dehyde-3-phosphate dehydrogenase. maximal expression of vsmNOS mRNA was observed
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In addition, glomerular cells are thoroughly digested
by proteinase K to obtain clear mRNA expression
(Methods). This proteinase K digestion causes a reduc-
tion in the number of glomerular cells and makes the
surface and thickness of sections uneven (DNase-treated
controls; Fig. 5). Therefore, the in situ RT-PCR analysis
is not a useful means of evaluating levels of mRNA
expression in cells.
The expression of vsmNOS mRNA was detected in
the cytoplasm of mesangial and epithelial cells from SOC
rats and rats with UUO, indicating that the gene expres-
sion of vsmNOS in glomeruli originates in these cells.
In a positive control that was not treated with DNase,Fig. 4. PCR amplification of vsmNOS (600 bp) and GAPDH (515 bp)
cDNA obtained by reverse transcription of 1 mg RNA isolated from the amplification of vsmNOS mRNA and cDNA was
glomeruli of sham-operated control rats and rats with unilateral ureteral identified in the cytoplasm of mesangial and epithelialobstruction that were pretreated with saline or the angiotensin-con-
cells and in the nucleus of glomerular cells, respectively.verting enzyme inhibitor, enalapril. Each cDNA was amplified with 40
cycles using specific primers. (A) and (D) present cDNA from glomeruli However, the amplification of vsmNOS mRNA and
of the sham-operated control kidney. (B) and (E) present cDNA from cDNA was not observed in a negative control whereglomeruli of the contralateral, nonobstructed kidney. (C) and (F) pres-
AmpliTaq DNA polymerase was not added (not shown).ent cDNA from glomeruli of the obstructed kidney. Abbreviations are:
PCR, polymerase chain reaction; vsmNOS, vascular smooth muscle- Figure 6 presents representative photomicrographs of
derived inducible nitric oxide synthase; GAPDH, glyceraldehyde-3- the immunohistochemical staining for iNOS protein inphosphate dehydrogenase.
glomeruli from SOC rats and rats with UUO of three
hours duration that were pretreated or not with enalapril.
In glomeruli of the CLK and OK from rats with UUO,
in glomeruli of the CLK and OK from rats with UUO the expression of iNOS protein was detected in mesan-
of three hours duration. Thus, glomeruli from rats at gial and epithelial cells. The expression of iNOS protein
three hours following sham operation or UUO were used was substantially intensified in glomeruli of the OK as
to evaluate the effect of enalapril on the expression of compared to those of the CLK. However, immunoiden-
vsmNOS mRNA (Fig. 4). tifiable amounts of iNOS protein were not observed in
Levels of vsmNOS mRNA were significantly greater glomeruli from SOC rats.
by 3.3 and 5.1 times in glomeruli of the CLK and OK Prior administration of enalapril reduced the expres-
from rats with UUO, respectively, than in those of the sion of iNOS protein in glomeruli of the CLK and OK
kidneys from SOC rats. Likewise, levels of vsmNOS from rats with UUO, consequently resulting in no ex-
mRNA were substantially increased by 1.6 times in glo- pression of iNOS protein in glomeruli of the UUO set-
meruli of the OK when compared to those of the CLK. ting. Enalapril produced no effects on the expression of
Pretreatment of rats with enalapril, however, decreased iNOS protein in glomeruli from SOC rats. It is suggested
the expression of vsmNOS mRNA in glomeruli of the that the quantity of iNOS protein present in glomeruli
CLK and OK from rats with UUO to levels comparable from SOC rats that were pretreated or not with enalapril
to that seen in glomeruli from SOC rats. Enalapril had or rats with UUO that were pretreated with enalapril
no effects on the expression of vsmNOS mRNA in glo- was below the limit of detection of the antibody, used
meruli from SOC rats. because detectable amounts of vsmNOS and macNOS
Figure 5 shows representative photomicrographs of mRNA existed in glomeruli of these settings.
the in situ RT-PCR analysis representing the localization
of vsmNOS mRNA expression in glomeruli from rats at
DISCUSSIONthree hours following sham operation or UUO. Ordi-
The present study demonstrates the enhanced expres-narily, the in situ RT-PCR technique amplifies not only
sion of vsmNOS mRNA in glomeruli of the CLK andthe objective mRNA, but also the target cDNA in cells
OK from rats with UUO. The expression of vsmNOSthat are not treated with DNase through the process
of RT to PCR. However, this technique amplifies the mRNA was significantly greater in glomeruli of the OK
than in those of the CLK. Prior administration of enala-objective mRNA alone in cells that are treated with
DNase because genomic DNA in cells is decomposed pril, however, restored the enhanced expression of
vsmNOS mRNA observed in glomeruli of the CLK andby this enzyme (discussed in the Methods section). Ac-
cordingly, the message for the objective mRNA obtained OK from rats with UUO to levels similar to that seen
in glomeruli from SOC rats. Indeed, it is well knownby the in situ RT-PCR analysis is observed in the cyto-
plasm of cells. that endogenous angiotensin II is elevated shortly after
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Fig. 5. Representative photomicrographs of vsmNOS mRNA expression in glomeruli from sham-operated control rats and rats with unilateral
ureteral obstruction. (A) DNase-treated controls that are not amplified by means of in situ RT-PCR. The sections received proteinase K digestion
prior to DNase treatment (see Methods section). Arrows show mesangial and epithelial cells. (B) Photomicrographs obtained by means of in situ
RT-PCR. Arrows show the staining of vsmNOS mRNA in the cytoplasm of mesangial and epithelial cells. Microscopic magnification: 3400.
Abbreviations used: vsmNOS, vascular smooth muscle-derived inducible nitric oxide synthase; RT-PCR, reverse transcription-polymerase chain
reaction; CLK, contralateral, nonobstructed kidney; OK, obstructed kidney.
the onset of ureteral obstruction [6]. Collectively, these after inhibition of angiotensin II production in vivo by
enalapril (Fig. 3).observations indicate that UUO may potentiate the ex-
pression of vsmNOS mRNA in glomeruli of the CLK To determine the localization of vsmNOS mRNA in
glomeruli, we developed the in situ RT-PCR technique,and OK through enhanced effects of endogenous angio-
tensin II caused after the induction of ureteral ligation. a novel method for mRNA identification in cells using
tissue sections. The in situ RT-PCR analysis revealedOf greater importance in the present study is the find-
ing that in rats with UUO glomeruli of the OK exhibited that the expression of vsmNOS mRNA in glomeruli was
located in mesangial and epithelial cells in SOC ratsgreater expression of vsmNOS mRNA than those of
the CLK. This may be due to differences in levels of and rats with UUO. As described earlier (Fig. 3), the
expression of vsmNOS mRNA was significantly greaterangiotensin II affecting the two kidneys in vivo: the OK
influenced by increased levels of both circulating and in glomeruli of rats with UUO than in those of SOC rats.
These observations indicate that enhanced expression ofintrarenal, local angiotensin II versus the CLK exposed
to elevated levels of circulating angiotensin II alone. In vsmNOS mRNA observed in glomeruli from rats with
UUO may have occurred because glomerular mesangialfact, intrarenal angiotensin II is higher in the OK than
in the CLK of rats with UUO [7, 18]. This may also and epithelial cells of rats with UUO were exposed to
endogenous angiotensin II upregulated after the onsetexplain greater suppression of vsmNOS mRNA in glo-
meruli of the OK than in those of the CLK animals of ureteral obstruction.
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Fig. 6. Representative photomicrographs of iNOS
protein expression in glomeruli from sham-oper-
ated control rats and rats with unilateral ureteral
obstruction obtained by the immunohistochemi-
cal study. These rats were treated with saline or
the angiotensin-converting enzyme inhibitor, ena-
lapril, prior to sham operation or unilateral ure-
teral obstruction. Arrows show the staining of iNOS
protein in mesangial and epithelial cells. Micro-
scopic magnification: 3400. Abbreviations are:
iNOS, inducible nitric oxide synthase; CLK, con-
tralateral, nonobstructed kidney; OK, obstructed
kidney.
The immunohistochemical analysis demonstrated the mRNA expression, but not macNOS mRNA expression,
in glomeruli from SOC rats and rats with UUO that wereexistence of iNOS protein in glomerular mesangial and
epithelial cells of rats with UUO. The localization of pretreated or not with enalapril. There is 80% homology
between the sequence of vsmNOS and macNOS proteinsiNOS protein was consistent with that of vsmNOS
mRNA. Immunoreactive iNOS protein was substantially [2]. Thus, these results suggest that iNOS protein ex-
pressed in glomeruli of the CLK and OK from rats withincreased in glomeruli of the OK relative to those of the
CLK. Also, iNOS protein was more highly expressed in UUO of three hours duration primarily originates in
enhanced gene expression of glomerular vsmNOS re-glomeruli of the CLK from rats with UUO than in those
of SOC rats. Enalapril pretreatment decreased the ex- sulting from ureteral obstruction.
Of interest in the present study is that vsmNOS mRNApression of iNOS protein in glomeruli of the CLK and
OK from rats with UUO to levels comparable to that was constitutively expressed in glomeruli from SOC rats.
The physiologic role of vsmNOS mRNA expression isseen in glomeruli of SOC rats. The abundance of iNOS
protein was paralleled by the magnitude of vsmNOS not evident in glomeruli of the normal kidney. Several
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reports, however, suggest that NO derived from constitu- caused in the OK as a consequence of ureteral obstruc-
tion, suggesting that vsmNOS plays a role in activationtively expressed iNOS protein plays a role in maintaining
and regulating renal blood flow [2, 17, 19]. It is therefore of soluble guanylyl cyclase mediated by the AT1 receptor.
In addition, the expression of vsmNOS mRNA in glo-possible that constitutively expressed vsmNOS mRNA
in glomeruli of the normal kidney partially participates meruli was observed in mesangial and epithelial cells.
Also, Chevalier et al have documented that the activitiesin driving glomerular hemodynamics.
Following UUO, there is a progressive increase in of soluble and particulate guanylyl cyclase in glomeruli
are primarily localized to mesangial and epithelial cells,renal blood flow (RBF) in the OK, which peaks at ap-
proximately two to three hours after the onset of ureteral respectively [21]. Taken together, it is suggested that NO
produced by vsmNOS in glomerular mesangial and epithe-obstruction [6]. Thereafter, RBF falls progressively and
diminishes to approximately 30 to 40% of control values lial cells participates in the activation of soluble guanylyl
cyclase primarily present in glomerular mesangial cellsby 24 hours following ureteral ligation [6]. It is consid-
ered that the initial increase in RBF observed in the in an autocrine and/or paracrine fashion in the OK.
In summary, the present study demonstrates, to ourOK may be mediated by the vasodilatory prostaglandin,
prostacyclin [6]. In the CLK, however, RBF fluctuates knowledge for the first time, that UUO leads to a signifi-
cant increase in the expression of vsmNOS mRNA inand is not constant during the period, while it tends to
rise initially [20]. In the present study, the expression glomeruli from the OK and, to a lesser extent, in glomer-
uli from the CLK. In glomeruli vsmNOS mRNA is lo-of vsmNOS mRNA involved in the generation of the
vasodilatory/cytotoxic gas, NO was significantly in- cated in mesangial and epithelial cells. Endogenous an-
giotensin II may be the major mechanism responsiblecreased in glomeruli from rats with UUO versus SOC
rats by three hours after the induction of ureteral liga- for the increased expression of vsmNOS mRNA seen in
glomeruli from the CLK and OK. Additionally, the intion. There were no significant morphological changes
in glomeruli of the CLK and OK from rats with UUO situ RT-PCR technique may be a readily available tool
to determine the localization and distribution of mRNA(not shown). The pathophysiologic role of the increased
expression of vsmNOS mRNA observed in glomeruli in tissue.
from the CLK and OK is not immediately apparent.
However, it may be worth exploring if NO biosynthe- ACKNOWLEDGMENTS
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